{"url_path":"/fda/drug/recalls/D-0553-2026","section_key":"summary","section_title":"DRUG Recall: Wisconsin Pharmacal Company — MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-24","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0553-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Wisconsin Pharmacal Company"},"word_count":80,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0553-2026\n\n**Recalling firm:** Wisconsin Pharmacal Company\n**Classification:** Class I\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-24\n**Report date:** 2026-05-27\n\n## Product\nMG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.\n\n## Reason\nMicrobial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.\n\n## Affected lots\nLot #: 1024088, Exp 11/30/2026\n\n## Distribution\nUSA Nationwide and Bahamas"}